MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$1,708,000
Net Income
-$7,391,000
Net Profit Margin
-432.73%
EPS
-$0.04
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Contract revenue
1,708,000
1,708,000
1,461,000
0
Research and development
5,017,000
5,161,000
4,909,000
3,221,000
General and administrative
5,519,000
4,886,000
5,087,000
4,036,000
Impairment loss
-
-
0
-
Total operating expenses
10,536,000
10,047,000
9,996,000
7,257,000
Loss from operations
-8,828,000
-8,339,000
-8,535,000
-7,257,000
Interest income and other, net
415,000
412,000
383,000
68,000
Interest expense and other, net
8,000
88,000
346,000
725,000
Loss on extinguishment of debt
-
-
-576,000
-
Net loss
-8,421,000
-8,015,000
-9,074,000
-7,914,000
Net gain attributable to non-controlling interest
-1,030,000
-982,000
1,231,000
-2,502,000
Net loss attributable to rani therapeutics holdings, inc
-7,391,000
-7,033,000
-10,305,000
-5,412,000
Basic EPS
-0.04
-0.04
0.089
-0.12
Diluted EPS
-0.04
-0.04
0.089
-0.12
Basic Average Shares
187,168,000
179,996,000
-116,161,448
46,444,000
Diluted Average Shares
187,168,000
179,996,000
-116,161,448
46,444,000
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss
attributable to rani...
-$7,391,000
(-10.45%↓ Y/Y)
Net gain
attributable to...
-$1,030,000
(77.27%↑ Y/Y)
Net loss
-$8,421,000
(24.97%↑ Y/Y)
Interest income and
other, net
$415,000
(162.66%↑ Y/Y)
Loss from operations
-$8,828,000
(15.96%↑ Y/Y)
Contract revenue
$1,708,000
Interest expense and
other, net
$8,000
(-99.09%↓ Y/Y)
Total operating
expenses
$10,536,000
(0.30%↑ Y/Y)
General and
administrative
$5,519,000
(10.38%↑ Y/Y)
Research and development
$5,017,000
(-8.86%↓ Y/Y)
Buy us a coffee
Rani Therapeutics Holdings, Inc. (RANI)
Rani Therapeutics Holdings, Inc. (RANI)